持续性盆腔痛管理的治疗推荐:国际临床实践指南的系统综述
该研究检索多个数据库至2021年6月,纳入20部关于成年女性泌尿妇科疾病管理的临床实践指南,用AGREE-II工具评价质量,汇总270条治疗推荐。指南在范围和目的、清晰度领域平均优秀,其他领域一般或差,仅4部被推荐使用;推荐多集中于药物和手术干预,心理、物理治疗等保守干预推荐不一。结论认为持续性盆腔痛指南质量总体较差。
要点
- 共纳入20部指南,覆盖7种疾病,汇总270条治疗推荐。
- 仅4部指南被推荐使用,分别为子宫内膜异位症(NICE、RANZCOG、ESHRE)和多囊卵巢综合征(Teede等2018)。
- 药物和手术干预推荐最多,心理、物理治疗等保守干预推荐不一致。
核心结论
- 持续性盆腔痛临床实践指南的质量总体较差;多部指南认可应考虑持续性盆腔痛生物心理社会因素,但多数推荐药物、手术及其他生物医学干预。
研究设计与样本
- 系统综述,检索MEDLINE、CENTRAL、EMBASE、EmCare、SCOPUS、Cochrane系统综述数据库、Web of Science核心合集及相关指南数据库,检索时间自建库至2021年6月,筛选1379条记录,纳入20部指南。
- 纳入标准为成年女性泌尿妇科疾病管理、英文发表、任何出版日期、由专业组织或学会认可的临床实践指南。
- 采用AGREE-II工具评价指南质量,描述性综合汇总各指南的治疗推荐。
主要发现
- 7种疾病的指南共提供270条个体推荐。
- 质量评价中,范围和目的领域平均得分80.6%(SD=13.3),清晰度和呈现领域平均得分74.4%(SD=12.0),均为优秀;其他领域平均得分为满意或差。
- 4部指南被推荐使用:子宫内膜异位症指南(NICE、RANZCOG、ESHRE)和多囊卵巢综合征指南(Teede等2018,国际循证指南,Monash大学,墨尔本,澳大利亚)。
- 推荐最频繁的是药物和手术干预;心理、物理治疗及其他保守干预的推荐不一致。
关键数值与推荐
- 指南质量评价采用AGREE-II工具,范围和目的领域平均80.6%(SD=13.3),清晰度和呈现领域平均74.4%(SD=12.0)。
- 被推荐使用的指南包括NICE、RANZCOG和ESHRE的子宫内膜异位症指南,以及Teede等2018的多囊卵巢综合征国际循证指南。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Females with persistent pelvic pain (PPP) report great variability in the treatments recommended to them despite the availability of clinical practice guidelines (CPGs) that aim to standardise care. A clear consensus for the best practice care for PPP is required. OBJECTIVE: To identify and summarise treatment recommendations across CPGs for the management of PPP, and appraise their quality. SEARCH STRATEGY: MEDLINE, CENTRAL, EMBASE, EmCare, SCOPUS, the Cochrane Database of Systematic Reviews, Web of Science Core Collection and relevant guideline databases were searched from their inception to June 2021. SELECTION CRITERIA: Included CPGs were those for the management of urogynaecological conditions in adult females published in English, of any publication date, and endorsed by a professional organisation or society. DATA COLLECTION AND ANALYSIS: We screened 1379 records and included 20 CPGs. CPG quality was assessed using The Appraisal of Guidelines for Research and Evaluation II (AGREE-II) tool. Descriptive synthesis compiled treatment recommendations across CPGs. MAIN RESULTS: The CPGs for seven conditions provided 270 individual recommendations. On quality appraisal, guidelines on average scored 'excellent' for the domains 'scope and purpose' (80.6%, SD = 13.3) and 'clarity and presentation' (74.4%, SD = 12.0); for other domains, average scores were satisfactory or poor. Four guidelines (for Endometriosis: NICE, RANZCOG and ESHRE; for polycystic ovary syndrome: Teede et al. 2018, International Evidence Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome, Monash University, Melbourne, Australia) were deemed recommended for use. Recommendations were most frequent for pharmaceutical and surgical interventions. Recommendations were variable for psychological, physiotherapy and other conservative interventions. CONCLUSIONS: The quality of CPGs for PPP is generally poor. Several CPGs endorse the consideration of biopsychosocial elements of PPP. Yet most recommend pharmaceutical, surgical and other biomedical interventions.
引用
- Mardon AK, Leake HB, Szeto K, et al. Treatment recommendations for the management of persistent pelvic pain: a systematic review of international clinical practice guidelines. BJOG. 2022. PMID: 34919325. doi:10.1111/1471-0528.17064
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。